HY2CARE
LIVE

Serial Number

79334421

Owner

Hy2Care B.V.

Attorney

Bradley M. Stohry

Filing Date

Oct 20, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HY2CARE Trademark

Serial Number: 79334421 • Registration: 7095412

HY2CARE is a trademark filed by Hy2Care B.V. on October 20, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Hy2Care B.V. (3 trademarks)

Urmonderbaan 22

Entity Type: 26

Trademark Details

Filing Date

October 20, 2021

Registration Date

July 4, 2023

Published for Opposition

April 18, 2023

Goods & Services

Medical services, namely, cartilage repair in the human body; medical services, namely, pain management and inflammation reduction in the human body; medical services, namely, bone repair in the human body; dermatology services for the human body; dentistry services for the human body; surgical treatment services, namely, surgery of the human body; medical services for the diagnosis of conditions of the human body; drug screening of the human body for medical purposes; drug screening of the human body for medical purposes involving application of liquid polymers; drug screening of the human body for medical purposes involving application of hydrogels

Medical devices, namely, injection needles; medical devices, namely, syringes; medical devices for injection of liquid components in the human and animal body, namely, injection needles; medical devices for injection of liquid polymers in the human and animal body, namely, injection needles; medical devices for injection of hydrogels in the human and animal body, namely, injection needles; medical devices for supply of pharmaceutical products for cartilage repair to the human and animal body, namely, injection instruments with needles; medical devices for supply of pharmaceutical products for bone repair to the human and animal body, namely, injection instruments with needles; medical devices for supply of dermal fillers to the human body, namely, injection needles; medical devices for supply of dental fillers to the human and animal body, namely, injection needles; medical devices for supply of dental fillers to the human and animal body, namely, syringes; medical devices for application of surgical glues and sealants to the human and animal body; diagnostic apparatus for medical purposes, namely, ultrasound diagnostic apparatus; diagnostic apparatus for medical purposes, namely, X-ray diagnostic apparatus; cell culture instruments for medical use, namely, cell culture chambers

Pharmaceutical compositions for cartilage repair and treatments; pharmaceutical compositions for pain management and inflammation reduction; pharmaceutical compositions for bone repair; pharmaceutical gels for cartilage repair and treatments; pharmaceutical gels for pain management and inflammation reduction; pharmaceutical gels for bone repair; injectable pharmaceuticals for cartilage repair and treatments; injectable pharmaceuticals for pain management and inflammation reduction; injectable pharmaceuticals for bone repair; pharmaceutical products containing liquid polymers for cartilage repair and treatments; pharmaceutical products containing liquid polymers for pain management and inflammation reduction; pharmaceutical products containing liquid polymers for bone repair; pharmaceutical products containing hydrogels for cartilage repair and treatments; pharmaceutical products containing hydrogels for pain management and inflammation reduction; pharmaceutical products containing hydrogels for bone repair; advanced therapy medicinal products for cartilage repair and treatments; advanced therapy medicinal products for pain management and inflammation reduction; advanced therapy medicinal products for bone repair; advanced therapy medicinal products containing liquid polymers for cartilage repair and treatments; advanced therapy medicinal products containing liquid polymers for pain management and inflammation reduction; advanced therapy medicinal products containing liquid polymers for bone repair; advanced therapy medicinal products containing hydrogels for cartilage repair and treatments; advanced therapy medicinal products containing hydrogels for pain management and inflammation reduction; advanced therapy medicinal products containing hydrogels for bone repair; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; medicated hydrogels for cartilage repair and treatments; medicated hydrogels for pain management and inflammation reduction; medicated hydrogels for bone repair; medicated hydrogels resorbable by the human and animal body for cartilage repair and treatments; medicated hydrogels resorbable by the human and animal body for pain management and inflammation reduction; medicated hydrogels resorbable by the human and animal body for bone repair; pharmaceutical products for cartilage repair and treatments; pharmaceutical products for pain management and inflammation reduction; pharmaceutical products for bone repair; injectable dermal fillers; dental fillers, namely, teeth filling material; surgical glues and sealants

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Oct 24, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 21, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 21, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 21, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 21, 2025 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 31, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 5, 2023 FICS
FINAL DISPOSITION PROCESSED
Oct 5, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 4, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 4, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 4, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Apr 19, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 18, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 29, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 29, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 23, 2022 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 4, 2022 RFCS
REFUSAL PROCESSED BY MPU
Aug 3, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 2, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 1, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 27, 2022 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 8, 2022 ADCH
APPLICATION FILING RECEIPT MAILED
Mar 1, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 24, 2022 REPR